Management of Diabetic Nephropathy

Introduction THE PATHOGENESIS AND CLINICAL DESCRIPTION OF DIABETIC NEPHROPATHY Type 2 Diabetes: Description and Epidemiology, P.H. Bennett and R.G. Nelson Type 1 Diabetes: Immunology, Genetics, and Epidemiology, S. Fourlanos, and T.W.H. Kay Diabetic Nephropathy: Epidemiology and Clinical Description, G. Jerums. S. Panagiotopoulos, and R. MacIsaac Inherited Susceptibility to Diabetic Nephropathy, M.C. Thomas Factors Influencing the Progression of Diabetic Nephropathy, B.F. Schrijvers, A.D. De Vriese, and A. Flyvbjerg THERAPEUTIC MEASURES IN PATIENTS WITH DIABETIC NEPHROPATHY Treatment of Diabetic Nephropathy: The Role of Strict Glucose Control, S. Thomas, M. Krimholtz, and G. Viberti Treatment of Diabetic Nephropathy: Anti-hypertensive Treatment, M. Ravid and R. Rachmani Treatment of Diabetic Nephropathy: Low-protein Diet, N.R. Waugh and A. Robertson Treatment of Diabetic Nephropathy: Control of Serum Lipids, K. Jandeleit-Dahm and F. Bonnet Diabetic Nephropathy: Treatment of Cardiac Complications, R. Candido and P. Srivastava Treatment of Diabetic Nephropathy: Acid-base and Electrolyte Disturbances, C.A. Pollack Novel approaches to the Treatment of Diabetic Nephropathy, R.G. Langham, D.J. Kelly, and R.E. Gilbert Summary of the Management of the Patient with Diabetic Nephropathy: Mild to Moderate Renal Involvement, R. Bilous and S. Jones The Treatment of Patients with Advanced Renal Involvement, D.J. van Dijk and G. Boner Pregnancy and Therapeutic Measures in the Patient with Diabetic Nephropathy, C. Ferrier and E. Gallery The Use of Dialysis in the Treatment of Patients with E-Stage Renal Disease, Y. Woredekal and E.A. Friedman Treatment of Diabetic Retinopathy in the Patient with Diabetic Nephropathy, R. Axer-Siegel and G. Dotan Treatment of Peripheral Vascular Disease and the Diabetic Foot in Patients with Diabetic Nephropathy, P.G. McNally and N. London The Use of Transplantation in the Treatment of Patients with End-Stage Renal Disease, E. Kendrick and G. Danovich Summary of the Therapeutic Approach to the Patient with Diabetes Nephropathy, G. Boner and M.E. Cooper Index

[1]  S. Arslanian.  Type 2 Diabetes in Children: Clinical Aspects and Risk Factors , 2004, Hormone Research in Paediatrics.

[2]  M. Cooper,et al.  Dual blockade of the renin–angiotensin system in diabetic nephropathy , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[3]  V. Somers,et al.  Heart Rate Variability: , 2003, Journal of cardiovascular electrophysiology.

[4]  R. Frye,et al.  Coronary Bypass Graft Patency in Patients With Diabetes in the Bypass Angioplasty Revascularization Investigation (BARI) , 2002, Circulation.

[5]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[6]  S. Yusuf,et al.  Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups , 2002, Circulation.

[7]  P. Savage,et al.  Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. , 2002, Diabetes.

[8]  M. Rutter,et al.  Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. , 2002, Journal of the American College of Cardiology.

[9]  M. Matsuda,et al.  Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. , 2002, Diabetes.

[10]  S. Taback,et al.  Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among native canadians. , 2002, Archives of pediatrics & adolescent medicine.

[11]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[12]  Sidney C. Smith,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients. , 2002, Circulation.

[13]  A. J. Reyes.  Diuretics in the therapy of hypertension , 2002, Journal of Human Hypertension.

[14]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[15]  D. Fedele,et al.  Experience with sildenafil in diabetes. , 2002, Diabetes, nutrition & metabolism.

[16]  R. Talbert,et al.  A Review of Vasopeptidase Inhibitors: A New Modality in the Treatment of Hypertension and Chronic Heart Failure , 2002, Pharmacotherapy.

[17]  R. Hanson,et al.  Genetics of diabetic nephropathy in the pima indians , 2001, Current diabetes reports.

[18]  J. Mehta,et al.  Angiotensin II via Activation of Type 1 Receptor Upregulates Expression of Endoglin in Human Coronary Artery Endothelial Cells , 2001, Hypertension.

[19]  P. Bennett,et al.  Type 2 diabetes, the thrifty phenotype - an overview. , 2001, British medical bulletin.

[20]  W. Frishman,et al.  Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. , 2001, Heart disease.

[21]  A. Jacobs,et al.  Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). , 2001, Journal of the American College of Cardiology.

[22]  J. Seidell,et al.  The association between antihypertensive drug therapies and plasma lipid levels in the general population , 2001, Journal of Human Hypertension.

[23]  J. Sabio,et al.  Effects of beta-blocker therapy in severe chronic heart failure. , 2001, The New England journal of medicine.

[24]  G. Becker,et al.  Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. , 2001, The New England journal of medicine.

[25]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.

[26]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[27]  Douglas G Altman,et al.  Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries , 2001, The Lancet.

[28]  G. Nichols,et al.  Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. , 2001, Diabetes care.

[29]  D R Jacobs,et al.  Dietary fat and incidence of type 2 diabetes in older Iowa women. , 2001, Diabetes care.

[30]  G. Fragasso,et al.  Recent advances in the diagnosis and treatment of diabetic cardiomyopathy. , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[31]  R. Page,et al.  Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. , 2001, American heart journal.

[32]  C. Bogardus,et al.  Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. , 2001, Diabetes.

[33]  M. Drazner,et al.  Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. , 2001, Journal of the American College of Cardiology.

[34]  D. Goldsmith,et al.  Important causes of hypoglycaemia in patients with diabetes on peritoneal dialysis , 2001, Diabetic Medicine.

[35]  P. Serruys,et al.  Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Study (ARTS) Trial , 2001, Circulation.

[36]  M. Pfisterer,et al.  Silent coronary artery disease in patients with diabetes mellitus. , 2001, Swiss medical weekly.

[37]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[38]  R. Hanson,et al.  Gamma globulin levels predict type 2 diabetes in the Pima Indian population. , 2001, Diabetes.

[39]  R. Doughty,et al.  Pseudonormal diastolic filling unmasked with glyceryl trinitrate in patients with type 2 diabetes with poor metabolic control. , 2001, Diabetes care.

[40]  R. Bilous,et al.  Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study , 2001, BMJ : British Medical Journal.

[41]  Jennifer Y. Liu,et al.  Glycemic Control and Heart Failure Among Adult Patients With Diabetes , 2001, Circulation.

[42]  J. Manson,et al.  Dietary fat intake and risk of type 2 diabetes in women. , 2001, The American journal of clinical nutrition.

[43]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[44]  T. Shoji,et al.  Glycemic control is a predictor of survival for diabetic patients on hemodialysis. , 2001, Diabetes care.

[45]  C. J. Smith,et al.  The effect of Indian or Anglo dietary preference on the incidence of diabetes in Pima Indians. , 2001, Diabetes care.

[46]  J M Dekker,et al.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. , 2001, JAMA.

[47]  C. Persson,et al.  EFFICACY AND SAFETY OF SILDENAFIL CITRATE FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH CARDIOVASCULAR DISEASE , 2001, International journal of clinical practice.

[48]  H. Krum.  New and emerging pharmacological strategies in the management of chronic heart failure. , 2001, Current opinion in pharmacology.

[49]  R. MacInnis,et al.  ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. , 2001, American journal of hypertension.

[50]  G. Francis,et al.  Diabetic cardiomyopathy: fact or fiction? , 2001, Heart.

[51]  F. Maklady,et al.  Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. , 2001, The American journal of cardiology.

[52]  P. Valensi,et al.  Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. , 2001, Diabetes care.

[53]  R. Nelson.  Diabetic renal disease in transitional and disadvantaged populations , 2001 .

[54]  R. Feldman,et al.  Quinapril treatment enhances vascular sensitivity to insulin , 2001, Journal of hypertension.

[55]  M. Cooper,et al.  Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study , 2000, BMJ : British Medical Journal.

[56]  A. Maseri,et al.  Myocardial Cell Death in Human Diabetes , 2000, Circulation research.

[57]  H. Parving,et al.  Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. , 2000, Diabetes care.

[58]  R. Hanson,et al.  Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. , 2000, Diabetes.

[59]  B. Howard,et al.  Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. , 2000, The American journal of cardiology.

[60]  T. Hedner,et al.  Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension–2 , 2000, Journal of hypertension.

[61]  O. Schnell,et al.  A new look at the heart in diabetes mellitus: from ailing to failing , 2000, Diabetologia.

[62]  H. Parving,et al.  Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. , 2000, Kidney international.

[63]  Tom H. Lindner,et al.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus , 2000, Nature Genetics.

[64]  C. Bogardus,et al.  A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. , 2000, The Journal of clinical investigation.

[65]  M. Pfeffer,et al.  Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial , 2000, The Lancet.

[66]  F. Messerli,et al.  Vasopeptidase inhibition and angio-oedema , 2000, The Lancet.

[67]  K. Malmberg,et al.  Heart failure and glucose abnormalities: an increasing combination with poor functional capacity and outcome. , 2000, European heart journal.

[68]  R. Hanson,et al.  The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. , 2000, Diabetes care.

[69]  V F Froelicher,et al.  American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. , 2000, Journal of the American College of Cardiology.

[70]  M. Ravid,et al.  Effect of Enalapril and Nifedipine on Orthostatic Hypotension in Older Hypertensive Patients , 2000, Journal of the American Geriatrics Society.

[71]  E. Aboud,et al.  Prevalence of renal artery stenosis in type 2 diabetes. , 2000, Diabetes & metabolism.

[72]  R. Hanson,et al.  Segregation analysis of diabetic nephropathy in Pima Indians. , 2000, Diabetes.

[73]  K. Takazawa,et al.  Is diabetes mellitus a major risk factor in coronary artery bypass grafting? The influence of internal thoracic artery grafting on late survival in diabetic patients. , 2000, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[74]  L. Monti,et al.  Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome. , 2000, Metabolism: clinical and experimental.

[75]  K. Sugimoto,et al.  A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats , 2000, Diabetologia.

[76]  Bertram Pitt,et al.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II , 2000, The Lancet.

[77]  M. Johannesson,et al.  Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study. , 2000, European heart journal.

[78]  E. Boyko,et al.  Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. , 2000, Diabetes care.

[79]  F. Nieto,et al.  Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .

[80]  A. Cowley,et al.  Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy , 1999, European journal of heart failure.

[81]  P. Douglas,et al.  Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway. , 1999, Journal of the American College of Cardiology.

[82]  C. Bogardus,et al.  Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. , 1999, Diabetes.

[83]  K. Malmberg,et al.  Diabetes and acute myocardial infarction: the role of insulin therapy. , 1999, American heart journal.

[84]  D. Tomlinson.  Mitogen-activated protein kinases as glucose transducers for diabetic complications , 1999, Diabetologia.

[85]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[86]  J. Shaw,et al.  Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality , 1999, Diabetologia.

[87]  T. Hirotani,et al.  Effects of coronary artery bypass grafting using internal mammary arteries for diabetic patients. , 1999, Journal of the American College of Cardiology.

[88]  P. Bennett,et al.  Effect of hypertension on mortality in Pima Indians. , 1999, Circulation.

[89]  D. Vergani,et al.  Prevalence of autoantibodies to autonomic nervous tissue structures in Type 1 diabetes mellitus , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[90]  S. Tanaka,et al.  Effect of calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes. , 1999, Journal of cardiovascular pharmacology.

[91]  R. Hanson,et al.  Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. , 1999, Diabetes care.

[92]  L. Groop.  Insulin resistance: the fundamental trigger of type 2 diabetes , 1999, Diabetes, obesity & metabolism.

[93]  D. Reda,et al.  Diuretics and β-Blockers Do Not Have Adverse Effects at 1 Year on Plasma Lipid and Lipoprotein Profiles in Men With Hypertension , 1999 .

[94]  E. Gilbert-Barness,et al.  Diabetic cardiomyopathy and carnitine deficiency. , 1999, Journal of diabetes and its complications.

[95]  M. Stevens,et al.  Heterogeneous cardiac sympathetic denervation and decreased myocardial nerve growth factor in streptozotocin-induced diabetic rats: implications for cardiac sympathetic dysinnervation complicating diabetes. , 1999, Diabetes.

[96]  L. Niskanen,et al.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.

[97]  O. Pedersen,et al.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study , 1999, The Lancet.

[98]  L. Ruilope.  Cardiovascular and renal risks of calcium-channel blockers--news from the HOT study. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[99]  Nancy J. Cox,et al.  Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans , 1999, Nature Genetics.

[100]  R. Schrier,et al.  Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial. , 1998, The American journal of cardiology.

[101]  A. Fitzgerald,et al.  Microalbuminuria and coronary heart disease in NIDDM: an incidence study. , 1998, Diabetes.

[102]  G. Pylypchuk.  ACE Inhibitor—Versus Angiotensin II Blocker–Induced Cough and Angioedema , 1998, The Annals of pharmacotherapy.

[103]  A. Manto,et al.  Hyperfiltration in patients with type I diabetes mellitus: a prevalence study. , 1998, Clinical nephrology.

[104]  M. Schwaiger,et al.  Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. , 1998, Circulation.

[105]  R. A. Norman,et al.  A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. , 1998, Diabetes.

[106]  D. Sutherland,et al.  Reversal of lesions of diabetic nephropathy after pancreas transplantation. , 1998, The New England journal of medicine.

[107]  M. Harris,et al.  Mortality in Adults With and Without Diabetes in a National Cohort of the U.S. Population, 1971–1993 , 1998, Diabetes Care.

[108]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[109]  M. Schwaiger,et al.  Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. , 1998, Journal of the American College of Cardiology.

[110]  A. Ziegler,et al.  Evidence for specific autoimmunity against sympathetic and parasympathetic nervous tissues in Type 1 diabetes mellitus and the relation to cardiac autonomic dysfunction , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[111]  H. Krum,et al.  Drug Administration in Patients with Diabetes Mellitus , 1998, Drug safety.

[112]  Farris K. Timimi,et al.  Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. , 1998, Circulation.

[113]  R. Hanson,et al.  Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. , 1998, Diabetes.

[114]  B. Davis,et al.  Influence of Long-term, Low-Dose, Diuretic-Based, Antihypertensive Therapy on Glucose, Lipid, Uric Acid, and Potassium Levels in Older Men and Women With Isolated Systolic Hypertension The Systolic Hypertension in the Elderly Program , 1998 .

[115]  M. Pahor,et al.  Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM , 1998, Diabetes Care.

[116]  G. Blohmé,et al.  The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[117]  T. Lehtimäki,et al.  Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.

[118]  V. Salomaa,et al.  Impact of Diabetes on Mortality After the First Myocardial Infarction , 1998, Diabetes Care.

[119]  M. Omata,et al.  Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. , 1997, Journal of the American College of Cardiology.

[120]  P. Fernyhough,et al.  Role of Neurotrophins in Diabetic Neuropathy and Treatment with Nerve Growth Factors , 1997, Diabetes.

[121]  M. Cotter,et al.  Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy , 1997, Diabetes.

[122]  R. Hanson,et al.  Breastfeeding and incidence of non-insulin-dependent diabetes mellitus in Pima Indians , 1997, The Lancet.

[123]  N. Chaturvedi.  Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria , 1997, The Lancet.

[124]  A. Ziegler,et al.  Autoantibodies to Sympathetic Ganglia, GAD, or Tyrosine Phosphatase in Long-Term IDDM With and Without ECG-Based Cardiac Autonomic Neuropathy , 1997, Diabetes Care.

[125]  P. Fiorina,et al.  Isolated and preclinical impairment of left ventricular filling in insulin‐dependent and non‐insulin‐dependent diabetic patients , 1997, Clinical cardiology.

[126]  K. Malmberg.  Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.

[127]  E. Rimm,et al.  Dietary Fiber, Glycemic Load, and Risk of NIDDM in Men , 1997, Diabetes Care.

[128]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[129]  L. Cardon,et al.  Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians. , 1997, American journal of human genetics.

[130]  S. Ozanne,et al.  The Thrifty Phenotype Hypothesis: How Does it Look After 5 Years? , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[131]  S. Nielsen,et al.  The clinical course of renal function in NIDDM patients with normo‐ and microalbuminuria , 1997, Journal of internal medicine.

[132]  G. Beck,et al.  Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. , 1996, The New England journal of medicine.

[133]  B. Rangoonwala,et al.  EFFICACY OF RAMIPRIL VERSUS ENALAPRIL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION , 1996, The British journal of clinical practice.

[134]  J Herlitz,et al.  Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. , 1996, European heart journal.

[135]  E. Grossman,et al.  Diabetic and Hypertensive Heart Disease , 1996, Annals of Internal Medicine.

[136]  A. Ziegler,et al.  Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients , 1996, Diabetologia.

[137]  Eraldo Paulesu,et al.  Silent Ischemia as a Central Problem: Regional Brain Activation Compared in Silent and Painful Myocardial Ischemia , 1996, Annals of Internal Medicine.

[138]  S. Lillioja,et al.  Interrelationships between muscle morphology, insulin action, and adiposity. , 1996, The American journal of physiology.

[139]  B. Capaldo,et al.  Diastolic Dysfunction in Patients with Non‐insulin‐dependent Diabetes Mellitus of Short Duration , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[140]  M. Creager,et al.  -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .

[141]  P. McKeigue,et al.  Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years , 1996, BMJ.

[142]  P. Bennett,et al.  Sequential Trends in Overall and Cause-Specific Mortality in Diabetic and Nondiabetic Pima Indians , 1996, Diabetes Care.

[143]  N. Hardin,et al.  The myocardial and vascular pathology of diabetic cardiomyopathy. , 1996, Coronary artery disease.

[144]  N. Chaturvedi,et al.  Effect of intensive treatment in insulin dependent diabetes mellitus with microalbuminuria , 1996, BMJ.

[145]  M. Cotter,et al.  Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. , 1995, The Journal of clinical investigation.

[146]  J. Stengård,et al.  Dietary Factors Determining Diabetes and Impaired Glucose Tolerance: A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study , 1995, Diabetes Care.

[147]  H. Parving,et al.  Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[148]  K. Yano,et al.  Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. , 1995, Circulation.

[149]  L. Groop,et al.  Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM , 1995, Diabetologia.

[150]  P. Armstrong,et al.  Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. , 1995, Journal of the American College of Cardiology.

[151]  C. Bogardus,et al.  An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. , 1995, The Journal of clinical investigation.

[152]  D. Kramsch,et al.  Limits of lipid-lowering therapy: the benefits of amlodipine as an anti-atherosclerotic agent. , 1995, Journal of human hypertension.

[153]  B. Kasiske,et al.  Effects of Antihypertensive Therapy on Serum Lipids , 1995, Annals of Internal Medicine.

[154]  D. Ziegler,et al.  Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. , 1994, Diabetes/metabolism reviews.

[155]  S. Tesfaye,et al.  Vascular factors in diabetic neuropathy , 1994, Diabetologia.

[156]  V. Kuhlmeier,et al.  Prognostic significance of silent ischemia , 1994, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[157]  D. Jullien,et al.  Abnormalities suggestive of cardiomyopathy in patients with type 2 diabetes of relatively short duration. , 1994, Diabete & metabolisme.

[158]  M. Peakman,et al.  An Investigation of Antibodies to Nerve Growth Factor in Diabetic Autonomic Neuropathy , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[159]  R. Hanson,et al.  Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? , 1994, BMJ.

[160]  M. Creager,et al.  Impaired Endothelium‐Dependent Vasodilation in Patients With Insulin‐Dependent Diabetes Mellitus , 1993, Circulation.

[161]  S. Fava,et al.  Factors That Influence Outcome in Diabetic Subjects With Myocardial Infarction , 1993, Diabetes Care.

[162]  R. Bilous,et al.  Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys , 1993, The Lancet.

[163]  G. Murata,et al.  The Relationship Between Glycemic Control and Morbidity and Mortality for Diabetics on Dialysis , 1993, ASAIO journal.

[164]  D. Owens,et al.  Impact of initial treatment on renal function in newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus , 1993, Diabetologia.

[165]  G. Hutchins,et al.  Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[166]  K. Mizuno,et al.  Usefulness of plasma beta-endorphin level, pain threshold and autonomic function in assessing silent myocardial ischemia in patients with and without diabetes mellitus. , 1993, The American journal of cardiology.

[167]  J R Roelandt,et al.  Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. , 1993, Circulation.

[168]  T. Chalmers,et al.  Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes , 1993, The Lancet.

[169]  A. Doyle.  A review of the short-term benefits of antihypertensive treatment with emphasis on stroke. , 1993, American journal of hypertension.

[170]  G. Lanza,et al.  Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. , 1993, American journal of hypertension.

[171]  B. Kasiske,et al.  Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.

[172]  M. Shimizu,et al.  Collagen remodelling in myocardia of patients with diabetes. , 1993, Journal of clinical pathology.

[173]  P. Vallance,et al.  Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. , 1992, The Journal of clinical investigation.

[174]  C. Hales,et al.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis , 1992, Diabetologia.

[175]  W C Willett,et al.  A prospective study of exercise and incidence of diabetes among US male physicians. , 1992, JAMA.

[176]  M. Spüler,et al.  Prevalence of Cardiovascular Autonomic Dysfunction Assessed by Spectral Analysis and Standard Tests of Heart-Rate Variation in Newly Diagnosed IDDM Patients , 1992, Diabetes Care.

[177]  R. Klein,et al.  Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.

[178]  G. Bakris,et al.  Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. , 1992, Kidney international.

[179]  S. Björck.  Renal protective effect of enalapril in diabetic nephropathy: Author's reply , 1992, BMJ.

[180]  F. Kolář,et al.  Alterations in Ca2+-channels during the development of diabetic cardiomyopathy , 1992, Molecular and Cellular Biochemistry.

[181]  C. Mogensen.  Angiotensin converting enzyme inhibitors and diabetic nephropathy. , 1992, BMJ.

[182]  J. Tuomilehto,et al.  Beta-blockade in the primary prevention of coronary heart disease in hypertensive patients. Review of present evidence. , 1991, Circulation.

[183]  J. Christiansen,et al.  ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment. , 1991, Clinical and investigative medicine. Medecine clinique et experimentale.

[184]  J. Manson,et al.  Physical activity and incidence of non-insulin-dependent diabetes mellitus in women , 1991, The Lancet.

[185]  L. T. Sheffield,et al.  Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) Registry. , 1991, The American journal of cardiology.

[186]  R. Paffenbarger,et al.  Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. , 1991, The New England journal of medicine.

[187]  D. Levy,et al.  Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). , 1991, The American journal of cardiology.

[188]  P. Low,et al.  Oxygen Free Radical Effects in Sciatic Nerve in Experimental Diabetes , 1991, Diabetes.

[189]  J. Lancaster,et al.  Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. , 1991, The New England journal of medicine.

[190]  G Steiner,et al.  Detection of silent myocardial ischemia in diabetes mellitus. , 1991, The American journal of cardiology.

[191]  J M Neilson,et al.  Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. , 1991, British heart journal.

[192]  D. Ewing,et al.  Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients , 1991, Diabetologia.

[193]  B. Feldt-Rasmussen,et al.  Effect of improved metabolic control on loss of kidney function in Type 1 (insulin-dependent) diabetic patients: an update of the Steno studies , 1991, Diabetologia.

[194]  P. Bennett,et al.  A two-step model for development of non-insulin-dependent diabetes. , 1991, The American journal of medicine.

[195]  L. Hegedüs,et al.  Kidney volume in type 1 (insulin-dependent) diabetic patients with normal or increased urinary albumin excretion: effect of long-term improved metabolic control. , 1991, Scandinavian journal of clinical and laboratory investigation.

[196]  K. Airaksinen,et al.  Diabetic heart muscle disease. , 1990, Annals of medicine.

[197]  M. F. Saad,et al.  Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus , 1990, Diabetologia.

[198]  S. Haffner,et al.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? , 1990, JAMA.

[199]  R. Hellweg,et al.  Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy , 1990, Journal of neuroscience research.

[200]  J. Sotelo,et al.  Low serum levels of nerve growth factor in diabetic neuropathy , 1990, Acta neurologica Scandinavica.

[201]  P. Bennett,et al.  Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. , 1990, Diabetes/metabolism reviews.

[202]  H. R. Peterson,et al.  Autonomic influence on cardiovascular performance in diabetic subjects. , 1989, The American journal of medicine.

[203]  P. Bennett,et al.  SEQUENTIAL CHANGES IN SERUM INSULIN CONCENTRATION DURING DEVELOPMENT OF NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[204]  P. Bennett,et al.  Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. , 1989, Kidney international.

[205]  R. Williams,et al.  Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. , 1988, American journal of human genetics.

[206]  M. Rothschild,et al.  Temporary decrease in cardiac parasympathetic tone after acute myocardial infarction. , 1988, The American journal of cardiology.

[207]  T. Vilén,et al.  Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. , 1988, The New England journal of medicine.

[208]  J. Manson,et al.  A prospective study of moderate alcohol drinking and risk of diabetes in women. , 1988, American journal of epidemiology.

[209]  A. Malliani,et al.  Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. , 1988, Journal of the autonomic nervous system.

[210]  J. Madans,et al.  Mortality among diabetics in a national sample. , 1988, American journal of epidemiology.

[211]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[212]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[213]  D. Greene,et al.  Pathogenesis and prevention of diabetic neuropathy. , 1988, Diabetes/metabolism reviews.

[214]  M. Niemelä,et al.  Impaired vagal heart rate control in coronary artery disease. , 1987, British heart journal.

[215]  W. Beierwaltes,et al.  Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[216]  H. Keen,et al.  Metabolic control and progression of diabetic nephropathy. , 1987, Diabetologia.

[217]  R. Virmani,et al.  Sudden cardiac death. , 1987, Human pathology.

[218]  D. Greene,et al.  Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. , 1987, The New England journal of medicine.

[219]  G. Nyberg,et al.  Impact of metabolic control in progression of clinical diabetic nephropathy , 1987, Diabetologia.

[220]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[221]  Torsten Deckert,et al.  EFFECT OF TWO YEARS OF STRICT METABOLIC CONTROL ON PROGRESSION OF INCIPIENT NEPHROPATHY IN INSULIN-DEPENDENT DIABETES , 1986, The Lancet.

[222]  S. Haffner,et al.  Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. , 1986, The New England journal of medicine.

[223]  A. Vinik,et al.  Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease. , 1986, The Journal of clinical endocrinology and metabolism.

[224]  S. Lillioja,et al.  Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. , 1986, The Journal of clinical endocrinology and metabolism.

[225]  S. Behar,et al.  Two cases of sudden death documented by Holter monitor during Secondary Prevention Reinfarction Nifedipine Trial (SPRINT). , 1986, American heart journal.

[226]  V. Mohan,et al.  Serum immunoreactive insulin responses to a glucose load in Asian Indian and European Type 2 (non-insulin-dependent) diabetic patients and control subjects , 1986, Diabetologia.

[227]  L. Hegedüs,et al.  Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. , 1986, The New England journal of medicine.

[228]  P. Cohn,et al.  Silent myocardial ischemia: classification, prevalence, and prognosis. , 1985, The American journal of medicine.

[229]  R. Bilous,et al.  Eight-Month Correction of Hyperglycemia in Insulin-dependent Diabetes Mellitus Is Associated with a Significant and Sustained Reduction of Urinary Albumin Excretion Rates in Patients with Microalbuminuria , 1985, Diabetes.

[230]  M. Ravid,et al.  The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients. , 1985, Archives of internal medicine.

[231]  S. Lillioja,et al.  Relationship between insulin-mediated glucose disposal and lipid metabolism in man. , 1985, The Journal of clinical investigation.

[232]  H. Keen,et al.  Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. , 1985, The New England journal of medicine.

[233]  J. Pickup,et al.  Glycaemic control in diabetic nephropathy. , 1984, British medical journal.

[234]  C. Mogensen,et al.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.

[235]  H. King,et al.  Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. , 1983, American journal of epidemiology.

[236]  P. Zimmet,et al.  Genetics of diabetes in Nauru: Effects of foreign admixture, HLA antigens and the insulin-gene-linked polymorphism , 1983, Diabetologia.

[237]  R. Bilous,et al.  Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes , 1983, British medical journal.

[238]  D. Ewing,et al.  Diagnosis and management of diabetic autonomic neuropathy. , 1982, British medical journal.

[239]  R. Bilous,et al.  Correction of Exercise-induced Microalbuminuria in Insulin-dependent Diabetics After 3 Weeks of Subcutaneous Insulin Infusion , 1981, Diabetes.

[240]  B. Pitt,et al.  Myocardial imaging in man with I-123 meta-iodobenzylguanidine. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[241]  S. Factor,et al.  Capillary microaneurysms in the human diabetic heart. , 1980, The New England journal of medicine.

[242]  R. Rasch.  Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment , 1979, Diabetologia.

[243]  J. Pickup,et al.  Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. , 1979, The New England journal of medicine.

[244]  B. J. Peters,et al.  Alterations of postural and Valsalva responses in coronary heart disease. , 1977, The American journal of physiology.

[245]  S. Ahmed,et al.  Evidence for cardiomyopathy in familial diabetes mellitus. , 1977, The Journal of clinical investigation.

[246]  P. Gorden,et al.  Unexplained Hyperinsulinemia in Normal and “Prediabetic” Pima Indians Compared with Normal Caucasians: An Example of Racial Differences in Insulin Secretion , 1977, Diabetes.

[247]  K. Seyer-Hansen.  Renal hypertrophy in streptozotocin-diabetic rats. , 1976, Clinical science and molecular medicine.

[248]  C. Mogensen,et al.  Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment , 1975, Diabetologia.

[249]  A. Grishman,et al.  New type of cardiomyopathy associated with diabetic glomerulosclerosis. , 1972, The American journal of cardiology.

[250]  D L Eckberg,et al.  Defective cardiac parasympathetic control in patients with heart disease. , 1971, The New England journal of medicine.

[251]  G. D. Whedon,et al.  Nutrient intake of Pima Indian women: relationships to diabetes mellitus and gallbladder disease. , 1971, The American journal of clinical nutrition.

[252]  E. Ritz,et al.  Blood pressure and metabolic control as risk factors for nephropathy in Type 1 (insulin-dependent) diabetes , 2004, Diabetologia.

[253]  D. Bell,et al.  Diabetic cardiomyopathy. , 2003, Diabetes care.

[254]  G. Bakris,et al.  Type 2 Diabetes: RENAAL and IDNT—The Emergence of New Treatment Options , 2002, Journal of clinical hypertension.

[255]  D. Bell.  Treatment of heart failure in patients with diabetes: clinical update. , 2002, Ethnicity & disease.

[256]  D. Vaughan.  Angiotensin and vascular fibrinolytic balance. , 2002, American journal of hypertension.

[257]  G. Bakris,et al.  Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study , 2002, Journal of Human Hypertension.

[258]  S. O’Rahilly,et al.  Digenic inheritance of severe insulin resistance in a human pedigree , 2002, Nature Genetics.

[259]  Teven,et al.  EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY , 2001 .

[260]  P. Poirier,et al.  Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. , 2001, Diabetes care.

[261]  Anson,et al.  DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN , 2001 .

[262]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[263]  F. Bernini,et al.  Lipophilic calcium antagonists in antiatherosclerotic therapy , 2000, Current atherosclerosis reports.

[264]  E S Lander,et al.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.

[265]  O. Schnell,et al.  Autoantibodies against autonomic nervous tissues in type 2 diabetes mellitus: no association with cardiac autonomic dysfunction. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[266]  L. Cosmi,et al.  Reactive oxygen species and antioxidant status in essential arterial hypertension during therapy with dihydropyridine calcium channel antagonists. , 2000, La Clinica terapeutica.

[267]  P. Poulsen,et al.  Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study , 1999, Diabetologia.

[268]  J. Chan,et al.  Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus. , 1997, American Journal of Nephrology.

[269]  S. Thomas,et al.  Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[270]  N. Dhalla,et al.  Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats. , 1997, Metabolism: clinical and experimental.

[271]  D. Ewing.  Diabetic autonomic neuropathy and the heart. , 1996, Diabetes research and clinical practice.

[272]  P. Bennett,et al.  The development and course of renal disease among Pima Indians with non-insulin dependent diabetes mellitus , 1995 .

[273]  P. Lichtlen.  Risks and benefits of calcium antagonists. , 1995, Lancet.

[274]  B. Rodrigues,et al.  Myocardial substrate metabolism: implications for diabetic cardiomyopathy. , 1995, Journal of molecular and cellular cardiology.

[275]  康生 大久保,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study , 1995 .

[276]  H. White,et al.  Factors affecting outcome after recovery from myocardial infarction. , 1994, Annual review of medicine.

[277]  A Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[278]  G. Murata,et al.  Clinical associations of glycemic control in diabetics on CAPD. , 1993, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[279]  M. Marre,et al.  Glomerular hyperfiltration in type I, type II, and secondary diabetes. , 1992, Journal of diabetes and its complications.

[280]  P. Schwartz,et al.  Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. , 1992, Circulation.

[281]  M. Waite.  Alpha 1 blockers: antihypertensives whose positive metabolic profile with regard to hyperinsulinaemia and lipid metabolism cannot be ignored. , 1991, Journal of internal medicine. Supplement.

[282]  M. Swash,et al.  Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. , 1990, Journal of the American College of Cardiology.

[283]  J. McNeil,et al.  Comparison of early renal dysfunction in type I and type II diabetes: differing associations with blood pressure and glycaemic control. , 1988, Diabetes research and clinical practice.

[284]  H. Keen,et al.  Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. , 1984, Nephron.

[285]  C. Mogensen.  Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. , 1971, Scandinavian journal of clinical and laboratory investigation.